Hip fracture care and mortality among patients treated in dedicated COVID-19 and non-COVID-19 circuits.
Cristina Ojeda-ThiesJavier Cuarental-GarcíaElena García-GómezCarlos Hugo Salazar-ZamoranoJavier Alberti-MaroñoLuis Rafael Ramos-PascuaPublished in: European geriatric medicine (2021)
Separate circuits for patients with and without coronavirus infectious disease-19 provided adequate hip fracture care. We did not observe increased mortality rates among hip fracture patients with preoperatively confirmed or suspected coronavirus infectious disease-19, compared to negative cases and 2018-19. Delaying surgery among patients with severe respiratory illness until a favourable trend could be observed did not lead to increased mortality.
Keyphrases
- hip fracture
- infectious diseases
- sars cov
- coronavirus disease
- cardiovascular events
- healthcare
- palliative care
- respiratory syndrome coronavirus
- risk factors
- quality improvement
- coronary artery disease
- type diabetes
- pain management
- cardiovascular disease
- pulmonary embolism
- coronary artery bypass
- percutaneous coronary intervention
- affordable care act
- drug induced
- respiratory tract